Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon

Completed · Phase 4

Conditions studied: Type 1 Diabetes Mellitus

In brief

This study will test the hypothesis that a BAC (blood alcohol content) of 0.1% will not significantly alter the anti-hypoglycemic effect of mico-dose glucagon in individuals with type 1 diabetes.

Key facts

Study ID

NCT02516150

Run by

Massachusetts General Hospital

People needed

26

Starts

2016-03-01

Expected to finish

2017-06-01

Last updated by the study team

2017-08-31

Who can join

Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Massachusetts General Hospital Diabetes Research Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.